Reyon Pharmaceutical completes 9 billion won convertible bond issuance

PUBT · 2d ago
Reyon Pharmaceutical completes 9 billion won convertible bond issuance
  • Reyon Pharmaceutical completed its 9 billion won private placement of unsecured convertible bonds, with payment received on Oct. 28, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reyon Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261028800573), on October 28, 2026, and is solely responsible for the information contained therein.